Mark Rowh

Top leaders share simple ways to cultivate patient loyalty.

Evidence-based decisions can help guide end-of-life care.

Ways to help lessen the stress that can come with cancer treatments.

A Managed Healthcare Executive’s cancer management survey revealed support for the selected use of complementary and alternative medicine. Where do things stand in what some consider a promising treatment area?

As immunotherapy breaks through in cancer therapy, here are five things to know about this promising treatment.

Dealing with cancer is challenging enough for patients and providers. But even when their different perspectives are factored in, that’s not the whole story.

Cancer comes in different varieties and with different rates of occurrence. Test yourself on these facts about blood cancers.

New cancer developments and research can be challenging to sort through. Here are four misconceptions about cancer that you should know.

While promising new options keep entering the scene, high costs can be problematic to patients and healthcare organizations. Here are some ways to cope.

The latest lymphoma research continues to bring new hope for patents, families and care providers. In looking at such advances, here are four things to know.

Retaining members is important for any health plan. Obviously there will always be defections, but many can be prevented.

Cancer is one of the top deadliest diseases in the world and can be difficult to treat. We want to hear from you about your current challenges and what you think about future prospects in cancer therapy.

You can’t make every patient satisfied every time, but it’s worth a shot. Here are 10 simple strategies for providers to consider.

If it's true that a picture is worth a thousand words, the same can be said for numbers.  For any healthcare executive, a look at relevant statistics can be revealing. Here are some of the top stats to know.

When it comes to promising areas in the treatment of lymphoma and other blood cancers, gene therapy may be at the top of the list. Here’s why.

As a healthcare executive you may not conduct research or administer medications, but you can still play an important role in helping improve treatment for lymphoma as well as other blood cancers.  Here are five areas in which you can make an impact.